Background. Cu,Zn-superoxide-dismutase, Cu,Zn-SOD, can be obtained from dif
ferent sources with different anti-inflammatory activities. In this study w
e compared the antiinflammatory capacity of the marine yeast Debaryomyces h
anseii Cu,Zn-SOD (Dh-SOD) with that of bovine erythrocytes (Be-SOD) in a pr
eventive and a therapeutic fashion.
Methods. Edema was induced by carrageenan injection into the rat hind paw a
nd was evaluated using a mercury plethysmograph. Development of the inflamm
atory process was followed by volume displacement at time 0 (carrageenan in
jection), 1, 2, 3, 4, 5, 6, 9, 12, and 24 h thereafter. Three different SOD
doses were used in preliminary experiments to prevent edema: 10, 100, and
1,000 U/kg.
Results. The results indicate that, at the lowest dose (10 U/kg), both SOD
samples are effective in reducing inflammation in both the prostaglandin an
d amplification phases (-24.8% and -17.5% in the case of Be-SOD, and 11.8%
and -18.7% in the case of Dh-SOD, respectively) (p <0.05). At 100 U/kg, Be-
SOD also shows good anti-inflammatory activity in all edema phases (-27.1%
in the serotonin phase; -19.4% in the prostaglandin phase; and -20% in the
amplification phase) (p <0.05), but Dh-SOD was less effective (-10.9%, -9.1
%, and -5.7%). At the highest dose tested (1000 U/kg), Dh-SOD was, again, m
ore effective than Be-SOD in all three edema phases (-33.1% and - 1.5%; -17
.9% and -2.6%; and -13.8% and 6.7%, respectively) (p <0.05). When evaluated
as a therapeutic alternative, single doses of Dh-SOD at 1,000 U/kg, and Be
-SOD at 100 U/kg, both showed good anti-inflammatory activities( -31.7% and
-23.5%, respectively) (p <0.05).
Conclusion. For therapy purposes alone, Dh-SOD appears to be a better anti-
inflammatory agent than Be-SOD in carrageenan-induced edema. (C) 1999 IMSS.
Published by Elsevier Science Inc.